Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Mandibular and Maxillary Procedures

NCT00309322 is registered in ClinicalTrials.gov with Novalar Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00309322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00309322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Mandibular and Maxillary Procedures
Lead sponsor
Novalar Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
August 31, 2006
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, dental